There's no doubt about it: Cholesterol drugs have helped save millions of lives.
357516 items (357516 unread) in 46 feeds
World Health Organization
(806 unread)
Media
(278392 unread)
Bird Flu
(5966 unread)
Diabetes
(13170 unread)
Cholesterol
(5084 unread)
Cancer
(26846 unread)
HIV
(14544 unread)
Women
(9810 unread)
Men
(2898 unread)
There's no doubt about it: Cholesterol drugs have helped save millions of lives.
AstraZeneca PLC and Abbott Laboratories said Tuesday that the U.S. Food and Drug Administration has asked for more information about their Certriad cholesterol drug before approving it for sale.
A new study from Iowa State University's Nutrition and Wellness Research Center may give men a way to combat high cholesterol without drugs -- if they don't mind sprinkling some flaxseed into their daily diet.
The American Heart Association has endorsed fish oil and plant stanol supplements to help manage heart disease.
Adam Radwanski Looks deceiving in Ontario's generic-drug strategy Ontario Premier Dalton McGuinty watches Tarig Francis performs a demonstration in a chemistry lab at Carleton University in Ottawa yesterday.
WESTCHESTER, N.Y.a 'Dietary supplements promoted for their ability to support healthy cholesterol levels or lower cholesterol generally deliver ingredients such as phytosterols or policosanol.
Patients who are taking the highest approved dose of the cholesterol-lowering drug simvastatin may face increased risk for muscle injury compared with those taking lower doses or "possibly" other statins, the FDA warned on Friday.
Pfizer said it expects a positive decision by the end of May on the inclusion of new paediatric data on labelling in Europe for its cholesterol drug Lipitor after European drug regulators recommended the move.
Page 1,617 of the 2,400-page law signed by President Barack Obama this week -- the most sweeping change to U.S. health-care in 45 years -- sparked little of the debate surrounding the expansion of coverage to 32 million Americans or its tax on employeesa a oeCadillaca insurance plans.
There is an increased risk of muscle injury in patients taking the highest approved dose of simvastatin compared to patients taking lower doses of the drug -- which is marketed as Zocor -- or other statins, according to a March 19 FDA safety alert .
A March 19 article in Time Magazine about the use of statins in women and a recent statement from the U.S. Food and Drug Administration about the use of simvastatin in men and women have addressed both the benefits and side effects of statin therapy for elevated cholesterol values administered in an effort to reduce the risk of heart disease and ...
My total cholesterol is 140, my LDL is 55 and my HDL is 47. I am on simvastatin.
Spring is the start for fresh food all over North Carolina. Although it was a wet winter and it is a little early in the season, you can still track down some fresh products from local farmers.
Genzyme Corp. and Isis Pharmaceuticals Inc. today announced that data from a phase 3 study of mipomersen in patients with homozygous familial hypercholesterolemia were published in The Lancet.
Published: Sunday, March 14, 2010 at 9:16 p.m. Last Modified: Sunday, March 14, 2010 at 9:16 p.m. LOS ANGELES It seemed like a good idea at the time.
Based on new data, the FDA warned that higher doses of the cholesterol-lowering drug Zocor, sold generically as simvastatin, carry an increased risk of muscle injury.
Best Prices on Meridia. BUY MERIDIA. Online canada pharmacy. Ultram online no prescription.
FDA Drug Safety Communication: Ongoing safety review of high-dose Zocor* and increased risk of muscle injury Safety Announcement Additional Information for Patients Additional Information for Healthcare Professionals Data Summary Simvastatin Dose Limitations Safety Announcement [3-19-2010] Based on review of data from a large clinical trial and ...
Diabetes & metabolism , Vol. 29, No. 3. , pp. 201-205. Abstract Unlike LDL cholesterol, which is a major cardiovascular risk factor, HDL cholesterol plays an important anti-atherogenic role through reverse cholesterol transport from peripheral cells to the liver.
The Food and Drug Administration says the highest available dose of the cholesterol drug Zocor can cause muscle damage as well as severe and potentially lethal kidney damage.
It's well known that the prevalence of diabetes is on the rise. According to the Centers for Disease Control and Prevention , about 23.6 million, or nearly 8 percent of people in the United States, have diabetes, and 1.6 million new cases are diagnosed each year in people aged 20 and older.
Pfizer Inc may still be eager to buy generic drugmakers, after being outbid for Germany's Ratiopharm in an effort to shore up revenue as it braces for evaporating sales of its blockbuster Lipitor cholesterol treatment.
One of the primary goals of this weekly medical column has been to emphasize that the practice of medicine is all about managing statistical risks for benefit versus side effects.
Abbott Laboratories' cholesterol drug TriCor failed to significantly reduce the risk of heart attacks and strokes among diabetics in a large government-sponsored study, reinforcing doubts about the drug's usefulness despite its popularity.
Two types of intensive drug treatments have failed to reduce heart attacks in diabetics, researchers report.
Diabetics who seek to aggressively lower their blood pressure and cholesterol are not reducing their risk of a heart attack and could suffer negative side effects, a study released Sunday said.
I keep hearing that beans are good for you. But don't they cause inflammation, and shouldn't you avoid that? The You Docs: Clearing the air about beans and inflammation Athens Banner-Herald Published Tuesday, March 16, 2010 I keep hearing that beans are good for you.
A popular triglyceride-lowering drug that has been taken by millions of Americans failed to prevent heart disease in a big federal study being presented today.
Two sets of results from a large U.S. government-sponsored trial find that neither aggressive treatment of cholesterol nor of blood pressure lowers the risk of heart events in people with type 2 diabetes.
A new study shows a high dose of popular cholesterol pill Lipitor lowers risk of heart attack and stroke in some patients with both heart disease and kidney disease.
Abbott Laboratories sued to prevent Hayward-based Impax Laboratories Inc. from selling a generic version of the cholesterol drug TriLipix until 2025.
A drug taken for decades by millions of people with type 2 diabetes to prevent heart attacks, strokes and deaths offered no benefit in a broad group of patients, a study released Sunday shows.
This is achieved by adding fenofibrate to simvastatin. Only 20 of these patients need to be treated for 5 years to prevent one cardiovascular event.
Adding a triglyceride lowering drug to cholesterol fighting statins provided no additional protection from heart attack, stroke and death from heart disease in patients with Type 2 diabetes, according to data from a large study.
Key results from a landmark federal study are in, and the results are disappointing for diabetics: Adding drugs to drive blood pressure and blood-fats lower than current targets did not prevent heart problems, and in some cases caused harmful side effects.
A new drug, eprotirome, has been shown to significantly lower bad cholesterol, triglycerides and Lp , without the side effects that statins cause in many people.
Merck wants the FDA to know that its own rules on risk information in drug ads have actually made patients less likely to encounter safety information.
Vytorin and its sibling medicine Zetia, once growth drivers for Merck, are likely to continue losing sales, according to one Wall Street analyst.
Only half of all patients at high risk of heart disease are given correct targets for lowering their cholesterol levels according to a study of 25,250 patients in Germany published online 11 March in the European Heart Journal [1]. The study investigated the way primary care doctors assessed their patients' risk factors and other health problems ...
A new drug "cuts heart attack and stroke risk without side effects", according to the Daily Mail.
Once again, cholesterol-lowering statin drugs have been shown to be good for more than the heart.
Researchers will continue a study of a controversial Merck & Co. cholesterol drug after safety monitors decided data so far indicate the drug is safe and effective, the company said Thursday.
Only half of patients at high risk of heart disease are given the right targets for cutting their cholesterol and millions may suffer heart attack or stroke due to doctors' poor advice, scientists said on Thursday.
A single bag of baby spinach, which is packed with vitamins and nutrients, but low in saturated fat and cholesterol, can serve as the focal point in a wide variety of menu items.
A pensioner was refused a refund on his 1,500 sofa after staff blamed dark stains on the leather on his cholesterol medication which 'seeped out of his hair'. Paul Hepburn, 70, and wife Pat spent their savings on the brown couch but within months were shocked to find it was covered in small round marks.
I made a New Year's resolution to become a vegetarian. Or a mostly vegetarian. I've been thinking about it for a long time, but with young children who love meat and don't have the broadest palates, I think it's important to feed them protein any way I can get it in them.
CARLSBAD,A Calif. Bristol-Myers Squibb has paid Isis Pharmaceuticals a $6 million milestone payment for regulatory approval to begin an early-stage clinical trial of a cholesterol-lowering drug, Isis announced Monday.
Pharmaceutical companies boosted their spending on ads directly targeting consumers by barely 2 percent last year, according to data compiled by The Nielsen Co.
WASHINGTON -- Poll results, congressional head counts and federal deficits aren't the only numbers President Barack Obama has to worry about.
If you're thinking of buying a supplement to help control cholesterol levels, a trip to your local drug or health food store may reveal a dizzying array of choices.
Merck & Co. and its Schering unit is suing Teva Pharmaceutical Industries Ltd. to prevent it from selling a generic version of the cholesterol drug Vytorin in the United States until 2017.
Resverlogix Corp., without a marketed product, may accomplish what Pfizer Inc., the world's biggest drugmaker, couldn't: Creating a new medicine that fights heart disease by raising so-called good cholesterol.
Shares in Medivation Inc. fell 67.5 percent Wednesday on news that its Phase III trials of Alzheimer's drug candidate Dimebon missed all of the study's stated goals, smashing some high hopes on Wall Street.
Once again, cholesterol -lowering statin drugs have been shown to be good for more than the heart.
Published: Wednesday, March 3, 2010 at 1:00 a.m. Last Modified: Tuesday, March 2, 2010 at 5:01 p.m. Dear Dr.
According to the American Heart Association, about 100 million Americans have cholesterol problems, and fixing them isn't always easy.
Pfizer Inc, long in the doghouse with frustrated investors, is winning attention from some of the savviest hedge funds thanks to high-tech drugs and vaccines that it got when it paid $68 billion for Wyeth.
The Food and Drug Administration on Wednesday approved Prevnar 13, an expanded version of a vaccine to protect children against more forms of bacterial infections that can cause meningitis , pneumonia and other diseases.